Uncategorized
VIDEO: Oxurion introduces new clinical portfolio at OIS
CHICAGO At the Ophthalmology Innovation Summit at AAO, Patrik De Haes, MD, CEO of Oxurion, introduces the company’s new clinical portfolio with three separate molecules in clinical trials for the treatment of diabetic macular edema.